These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 33022072)
41. High Throughput Detection of 327 Drugs in Blood by LC-MS-MS with Automated Data Processing. Di Rago M; Pantatan S; Hargreaves M; Wong K; Mantinieks D; Kotsos A; Glowacki L; Drummer OH; Gerostamoulos D J Anal Toxicol; 2021 Feb; 45(2):154-183. PubMed ID: 32451548 [TBL] [Abstract][Full Text] [Related]
42. Investigation of an LC-MS-MS (QTrap) method for the rapid screening and identification of drugs in postmortem toxicology whole blood samples. Herrin GL; McCurdy HH; Wall WH J Anal Toxicol; 2005 Oct; 29(7):599-606. PubMed ID: 16419388 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair. Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371 [TBL] [Abstract][Full Text] [Related]
44. Ultraviolet-Visible and High-Resolution Mass Spectrometry for the Identification of Cyclopropyl-Fentanyl in the First Fatal Case in Spain. Matey JM; García-Ruíz C; Montalvo G; Gómez-Soro JC; Gutierrez-Delicado D; Rodríguez-Gallardo J; Martínez MA J Anal Toxicol; 2020 Dec; 44(8):927-935. PubMed ID: 32715311 [TBL] [Abstract][Full Text] [Related]
45. Validation of an ELISA method for screening methadone in postmortem blood. Juhascik M; Habbel S; Barron W; Behonick G J Anal Toxicol; 2006 Oct; 30(8):617-20. PubMed ID: 17132262 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of the One-Step ELISA kit for the detection of buprenorphine in urine, blood, and hair specimens. Cirimele V; Etienne S; Villain M; Ludes B; Kintz P Forensic Sci Int; 2004 Jul; 143(2-3):153-6. PubMed ID: 15240036 [TBL] [Abstract][Full Text] [Related]
47. Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology. Daniulaityte R; Carlson RR; Juhascik MP; Strayer KE; Sizemore IE Int J Drug Policy; 2019 Sep; 71():3-9. PubMed ID: 31146200 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of the Triage TOX Drug Screen Assay for Detection of 11 Drugs of Abuse and Therapeutic Drugs. Bang HI; Jang MA; Lee YW Ann Lab Med; 2017 Nov; 37(6):522-525. PubMed ID: 28840991 [TBL] [Abstract][Full Text] [Related]
49. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry. Fels H; Dame T; Sachs H; Musshoff F Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549 [TBL] [Abstract][Full Text] [Related]
51. Utility of ELISA screening for the monitoring of abstinence from illegal and legal drugs in hair and urine. Agius R; Nadulski T Drug Test Anal; 2014 Jun; 6 Suppl 1():101-9. PubMed ID: 24817055 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups. Lin CN; Nelson GJ; McMillin GA J Anal Toxicol; 2013; 37(1):30-6. PubMed ID: 23144203 [TBL] [Abstract][Full Text] [Related]
53. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device. Röhrich J; Zörntlein S; Becker J; Urban R J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540 [TBL] [Abstract][Full Text] [Related]
54. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test. Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436 [TBL] [Abstract][Full Text] [Related]
55. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). Krotulski AJ; Mohr ALA; Friscia M; Logan BK J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050 [TBL] [Abstract][Full Text] [Related]
56. Applicability of a Chemiluminescence Immunoassay to Screen Postmortem Bile Specimens and Its Agreement with Confirmation Analysis. Franzin M; Ruoso R; Concato M; Radaelli D; D'Errico S; Addobbati R Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612632 [TBL] [Abstract][Full Text] [Related]
57. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Remane D; Wetzel D; Peters FT Anal Bioanal Chem; 2014 Jul; 406(18):4411-24. PubMed ID: 24817357 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of immunochemical drug screenings of whole blood samples. A retrospective optimization of cutoff levels after confirmation-analysis on GC-MS and HPLC-DAD. Kroener L; Musshoff F; Madea B J Anal Toxicol; 2003; 27(4):205-12. PubMed ID: 12820742 [TBL] [Abstract][Full Text] [Related]
59. A UHPLC-MS-MS Method for the Determination of 84 Drugs of Abuse and Pharmaceuticals in Blood. Orfanidis A; Gika HG; Theodoridis G; Mastrogianni O; Raikos N J Anal Toxicol; 2021 Feb; 45(1):28-43. PubMed ID: 32369171 [TBL] [Abstract][Full Text] [Related]
60. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA. Marin SJ; Keith L; Merrell M; McMillin GA J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]